These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34997843)

  • 1. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
    Harder A
    Childs Nerv Syst; 2022 Apr; 38(4):705-713. PubMed ID: 34997843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
    Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
    Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients.
    Titze S; Peters H; Währisch S; Harder T; Guse K; Buske A; Tinschert S; Harder A
    Eur J Hum Genet; 2010 Jan; 18(1):81-7. PubMed ID: 19639020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
    Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
    Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.
    Faden DL; Asthana S; Tihan T; DeRisi J; Kliot M
    PLoS One; 2017; 12(1):e0170348. PubMed ID: 28099461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
    Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
    J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutional mismatch repair deficiency is the diagnosis in 0.41% of pathogenic NF1/SPRED1 variant negative children suspected of sporadic neurofibromatosis type 1.
    Perez-Valencia JA; Gallon R; Chen Y; Koch J; Keller M; Oberhuber K; Gomes A; Zschocke J; Burn J; Jackson MS; Santibanez-Koref M; Messiaen L; Wimmer K
    Genet Med; 2020 Dec; 22(12):2081-2088. PubMed ID: 32773772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.
    Bartelt-Kirbach B; Wuepping M; Dodrimont-Lattke M; Kaufmann D
    Neurogenetics; 2009 Feb; 10(1):79-85. PubMed ID: 18850118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene.
    Stark M; Assum G; Krone W
    Hum Genet; 1995 Nov; 96(5):619-23. PubMed ID: 8530015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
    McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
    Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor.
    Cohen-Barak E; Toledano-Alhadef H; Danial-Farran N; Livneh I; Mwassi B; Hriesh M; Zagairy F; Gafni-Amsalem C; Bashir H; Khayat M; Warrour N; Sher O; Marom D; Postovsky S; Dujovny T; Ziv M; Shalev SA
    Exp Dermatol; 2022 May; 31(5):775-780. PubMed ID: 34913528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
    Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
    Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin.
    Skuse GR; Kosciolek BA; Rowley PT
    Am J Hum Genet; 1991 Sep; 49(3):600-7. PubMed ID: 1715669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
    Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
    Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
    Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
    Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
    Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
    Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.